About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Market Cap
$0.47B
Employees
82
Listed Since
May 13, 2010
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cormedix.comPhone
908-517-9500
Headquarters
300 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
CIK
0001410098